GCM
EXAS

Glaxis Capital Management’s Exact Sciences EXAS Stock Holding History

Glaxis Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,190
Closed -$1.08M – 38
2020
Q4 		$1.08M Buy
+8,190
New +$990K 2.17% 14

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Glaxis Capital Management's EXAS Position: Q1 2021 in Review

Glaxis Capital Management sold out of Exact Sciences (EXAS) in Q1 2021, closing a stake of 8,190 shares — an estimated $1.08M sold.

Glaxis Capital Management first reported a position in EXAS in Q4 2020 and held it in 1 quarter. The position peaked at $1.08M in Q4 2020. 645 funds tracked by Wall St. Rank hold EXAS as of Q1 2021.

  • Glaxis Capital Management reported no remaining Exact Sciences position as of Q1 2021 after selling out during the quarter.
  • Glaxis Capital Management sold 8,190 Exact Sciences shares in Q1 2021, an estimated $1.08M.
  • Glaxis Capital Management first reported a position in Exact Sciences in Q4 2020 and held it in 1 quarter.
  • Glaxis Capital Management's Exact Sciences position peaked at $1.08M in Q4 2020.
  • 645 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2021.

Based on Glaxis Capital Management's 13F filing for Q1 2021, filed 10 May 2021.